Lamictal

Lamotrigine, the active ingredient in Lamictal, is an anticonvulsant presented as an oral tablet for oral use. It is employed to control seizures in patients with epilepsy and to stabilize mood in adults diagnosed with bipolar disorder. The medication works by modulating neuronal excitability, thereby reducing the frequency of seizure episodes and preventing mood swings associated with bipolar illness.

GNH USA supplies Lamictal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide.

Lamotrigine is an anticonvulsant that modulates neuronal excitability in seizure disorders and mood regulation. - Epilepsy: reduces the frequency and severity of seizure episodes. - Bipolar disorder: helps maintain mood stability and prevents depressive or manic episodes. - Partial seizures: controls focal onset seizures that may spread. - Generalized tonic‑clonic seizures: prevents convulsive episodes in generalized seizure types.

Lamotrigine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate pain in the head region. - Nausea: feeling of stomach upset or urge to vomit. - Rash: skin redness or irritation, often mild. - Fatigue: unusual tiredness or lack of energy. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Aseptic meningitis: inflammation of the meninges without infection. - Blood dyscrasias: such as agranulocytosis or severe leukopenia. - Severe liver injury: marked elevation of liver enzymes or hepatic failure. - Hypersensitivity reactions: including fever, lymphadenopathy, or organ involvement.

When prescribing lamotrigine, clinicians should consider several safety measures to minimize risks. - Dose titration: increase gradually to reduce the risk of rash. - Skin reactions: monitor patients for any rash or hypersensitivity signs. - Renal impairment: adjust dosage if renal function is reduced. - Concomitant valproate: avoid high lamotrigine doses as valproate raises plasma levels. - Pregnancy: discuss potential risks with the patient and consider alternatives. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original packaging.

Lamotrigine can affect, or be affected by, other medicines; awareness of key interactions helps maintain therapeutic effectiveness.

Major Interactions (Avoid): - Valproic acid: significantly increases lamotrigine plasma concentrations, raising toxicity risk. - Carbamazepine: reduces lamotrigine levels, potentially decreasing seizure control.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower lamotrigine concentrations, requiring monitoring. - Phenobarbital: can decrease lamotrigine exposure, affecting efficacy. - Rifampin: induces metabolism and may reduce lamotrigine levels. - Other enzyme‑inducing antiepileptics: may lower lamotrigine concentrations, necessitating dose adjustments.